Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA drops international device inspection pilot:

This article was originally published in Clinica

Executive Summary

After reviewing the results of a six-month pilot programme, the FDA has decided not to continue with a plan to have its district offices process routine international device establishment inspection reports. The programme results were inconclusive, the agency said, adding that new streamlined procedures by its Center for Devices and Radiological Health's Office of Compliance in Washington had resulted in "significant reductions" in both review times and in the time it takes to mail post-inspection letters to companies. This largely eliminated the need for the pilot programme, it said.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT082217

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel